A Study of BEZ235 in Adult Japanese Patients With Advanced Solid Tumors

PHASE1CompletedINTERVENTIONAL
Enrollment

35

Participants

Timeline

Start Date

October 31, 2010

Primary Completion Date

July 31, 2013

Study Completion Date

July 31, 2013

Conditions
Advanced Solid Tumor
Interventions
DRUG

BEZ235

Trial Locations (2)

650-0017

Novartis Investigative Site, Kobe

879-5593

Novartis Investigative Site, Yufu

Sponsors
All Listed Sponsors
lead

Novartis Pharmaceuticals

INDUSTRY